| - GRCh37:
- Chr22:42456283-42463314
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Pathogenic (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461722-42464598
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Pathogenic (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463949
- GRCh38:
- Chr22:42067945
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462770
- GRCh38:
- Chr22:42066766
| LOC126863160, NAGA | R181C | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458969
- GRCh38:
- Chr22:42062965
| NAGA | W273C | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42457021
- GRCh38:
- Chr22:42061017
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461799
- GRCh38:
- Chr22:42065795
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458863
- GRCh38:
- Chr22:42062859
| NAGA | P309S | Alpha-N-acetylgalactosaminidase deficiency type 1, Inborn genetic diseases | Uncertain significance (Mar 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42463181
- GRCh38:
- Chr22:42067177
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456311
- GRCh38:
- Chr22:42060307
| NAGA | I403T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456378
- GRCh38:
- Chr22:42060374
| NAGA | R381* | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461771
- GRCh38:
- Chr22:42065767
| NAGA | G244S | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461725
- GRCh38:
- Chr22:42065721
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463121
- GRCh38:
- Chr22:42067117
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456322
- GRCh38:
- Chr22:42060318
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Feb 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463837
- GRCh38:
- Chr22:42067833
| LOC126863160, NAGA | D86N | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42457091
- GRCh38:
- Chr22:42061087
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463838
- GRCh38:
- Chr22:42067834
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42457020
- GRCh38:
- Chr22:42061016
| NAGA | A337T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42459043-42459045
- GRCh38:
- Chr22:42063039-42063041
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462748
- GRCh38:
- Chr22:42066744
| LOC126863160, NAGA | S188T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456347
- GRCh38:
- Chr22:42060343
| NAGA | N391S | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464472
- GRCh38:
- Chr22:42068468
| LOC126863160, NAGA | N41K | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464504
- GRCh38:
- Chr22:42068500
| LOC126863160, NAGA | L31V | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463798
- GRCh38:
- Chr22:42067794
| LOC126863160, NAGA | P99A | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458950
- GRCh38:
- Chr22:42062946
| NAGA | L280V | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42459033
- GRCh38:
- Chr22:42063029
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464583
- GRCh38:
- Chr22:42068579
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jul 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456993
- GRCh38:
- Chr22:42060989
| NAGA | D346N | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456963
- GRCh38:
- Chr22:42060959
| NAGA | G356S | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464582
- GRCh38:
- Chr22:42068578
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463128
- GRCh38:
- Chr22:42067124
| LOC126863160, NAGA | E164A | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458945
- GRCh38:
- Chr22:42062941
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463282
- GRCh38:
- Chr22:42067278
| NAGA, LOC126863160 | G113C | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462719
- GRCh38:
- Chr22:42066715
| LOC126863160, NAGA | P198S | not provided, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42463802
- GRCh38:
- Chr22:42067798
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456431
- GRCh38:
- Chr22:42060427
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463136
- GRCh38:
- Chr22:42067132
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Feb 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463181
- GRCh38:
- Chr22:42067177
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463762
- GRCh38:
- Chr22:42067758
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458951
- GRCh38:
- Chr22:42062947
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Oct 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456409
- GRCh38:
- Chr22:42060405
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jul 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463133
- GRCh38:
- Chr22:42067129
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462738
- GRCh38:
- Chr22:42066734
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464591
- GRCh38:
- Chr22:42068587
| NAGA, LOC126863160 | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462695-42462696
- GRCh38:
- Chr22:42066691-42066692
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456347
- GRCh38:
- Chr22:42060343
| NAGA | N391T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42462769
- GRCh38:
- Chr22:42066765
| LOC126863160, NAGA | R181H | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458986
- GRCh38:
- Chr22:42062982
| NAGA | A268T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463804
- GRCh38:
- Chr22:42067800
| LOC126863160, NAGA | R97G | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Aug 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458917
- GRCh38:
- Chr22:42062913
| NAGA | A291T | Alpha-N-acetylgalactosaminidase deficiency type 1, Inborn genetic diseases | Uncertain significance (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42458966
- GRCh38:
- Chr22:42062962
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461855
- GRCh38:
- Chr22:42065851
| NAGA | D216N | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456944
- GRCh38:
- Chr22:42060940
| NAGA | G362E | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456408
- GRCh38:
- Chr22:42060404
| NAGA | V371I | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463254
- GRCh38:
- Chr22:42067250
| LOC126863160, NAGA | M122T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Nov 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458950
- GRCh38:
- Chr22:42062946
| NAGA | L280I | Alpha-N-acetylgalactosaminidase deficiency type 1 | Benign (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461732
- GRCh38:
- Chr22:42065728
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Sep 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461912
- GRCh38:
- Chr22:42065908
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463863
- GRCh38:
- Chr22:42067859
| LOC126863160, NAGA | I77T | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456294-42456295
- GRCh38:
- Chr22:42060290-42060291
| NAGA | S409fs | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464491
- GRCh38:
- Chr22:42068487
| LOC126863160, NAGA | R35H | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463176
- GRCh38:
- Chr22:42067172
| NAGA, LOC126863160 | W148* | Alpha-N-acetylgalactosaminidase deficiency type 1 | Pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461734-42461741
- GRCh38:
- Chr22:42065730-42065737
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Likely pathogenic (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42466290
- GRCh38:
- Chr22:42070286
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461804
- GRCh38:
- Chr22:42065800
| NAGA | V233M | Alpha-N-acetylgalactosaminidase deficiency type 2, Inborn genetic diseases, Alpha-N-acetylgalactosaminidase deficiency type 1
| Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42454559
- GRCh38:
- Chr22:42058555
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42455711
- GRCh38:
- Chr22:42059707
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42455553
- GRCh38:
- Chr22:42059549
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42454421
- GRCh38:
- Chr22:42058417
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42454353
- GRCh38:
- Chr22:42058349
| NAGA, WBP2NL | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42455180
- GRCh38:
- Chr22:42059176
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463769
- GRCh38:
- Chr22:42067765
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Uncertain significance (Jun 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42456228
- GRCh38:
- Chr22:42060224
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456176
- GRCh38:
- Chr22:42060172
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456113
- GRCh38:
- Chr22:42060109
| NAGA | | not provided, Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1
| Benign/Likely benign (Feb 23, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42454972
- GRCh38:
- Chr22:42058968
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42454799
- GRCh38:
- Chr22:42058795
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42454728
- GRCh38:
- Chr22:42058724
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42466695
- GRCh38:
- Chr22:42070691
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463133
- GRCh38:
- Chr22:42067129
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463126
- GRCh38:
- Chr22:42067122
| LOC126863160, NAGA | R165W | Alpha-N-acetylgalactosaminidase deficiency type 1, not provided, Alpha-N-acetylgalactosaminidase deficiency type 2
| Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42462729
- GRCh38:
- Chr22:42066725
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458955
- GRCh38:
- Chr22:42062951
| NAGA | A278V | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42464463
- GRCh38:
- Chr22:42068459
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Sep 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463137
- GRCh38:
- Chr22:42067133
| LOC126863160, NAGA | T161I | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2, not provided
| Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42463108
- GRCh38:
- Chr22:42067104
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42461883
- GRCh38:
- Chr22:42065879
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 2 | Conflicting interpretations of pathogenicity (Jun 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42461913
- GRCh38:
- Chr22:42065909
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458951
- GRCh38:
- Chr22:42062947
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42459001
- GRCh38:
- Chr22:42062997
| NAGA | L263I | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463259
- GRCh38:
- Chr22:42067255
| LOC126863160, NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458885
- GRCh38:
- Chr22:42062881
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Dec 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42458824
- GRCh38:
- Chr22:42062820
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Dec 31, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42456310
- GRCh38:
- Chr22:42060306
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 2, Alpha-N-acetylgalactosaminidase deficiency type 1 | Conflicting interpretations of pathogenicity (Sep 10, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr22:42456373
- GRCh38:
- Chr22:42060369
| NAGA | | Alpha-N-acetylgalactosaminidase deficiency type 1 | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463132
- GRCh38:
- Chr22:42067128
| LOC126863160, NAGA | E163K | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42463213
- GRCh38:
- Chr22:42067209
| LOC126863160, NAGA | D136H | Alpha-N-acetylgalactosaminidase deficiency type 1, Inborn genetic diseases | Uncertain significance (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:42466286
- GRCh38:
- Chr22:42070282
| NAGA | V6M | Alpha-N-acetylgalactosaminidase deficiency type 1 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr22:42457046
- GRCh38:
- Chr22:42061042
| NAGA | M328T | Inborn genetic diseases, not provided, Alpha-N-acetylgalactosaminidase deficiency type 1
| Uncertain significance (May 5, 2023) | criteria provided, multiple submitters, no conflicts |